Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Biotechnology industry stocks

The Biotechnology industry has 616 US-listed companies on stockrow and is part of the Healthcare sector, with a combined market value of $1.26T. Vertex Pharmaceuticals Incorporated (VRTX) is the largest at $132.3B, followed by Regeneron Pharmaceuticals, Inc. and Moderna, Inc.. The median Biotechnology stock trades at 7.9× trailing earnings, below the market median of 17.9×, with a median net margin of 0.00% (market: 0.55%). Median revenue growth over the last twelve months is 5.64%. 14 of the 616 pay a dividend; the median yield among payers is 2.10%.

Biotechnology medians

Metric Industry Market
P/E 7.9× 17.9×
P/S 11.5× 2.0×
P/B 2.5× 1.8×
Price to free cash flow 21.2× 14.0×
EV/EBITDA 0.7× 11.0×
EV/Sales 10.7× 2.2×
Earnings yield −28.8% 1.18%
Free cash flow yield −23.0% 0.48%
Gross margin 65.2% 46.3%
Operating margin 0.00% 0.00%
Net margin 0.00% 0.55%
Free cash flow margin 0.00% 0.00%
Return on equity −57.7% 1.76%
Return on assets −49.2% 0.00%
Return on invested capital 0.00% 0.00%
Revenue growth (TTM) 5.64% 7.41%
Revenue growth, 5-year CAGR 8.40% 8.85%
Net income growth, 5-year CAGR 0.00% 0.00%
Debt to equity 0.0× 0.2×
Current ratio 4.7× 1.6×
Net debt to EBITDA 1.0× 0.6×
Dividend yield 2.10% 2.75%
Payout ratio 0.0× 0.0×
Market cap $162.1M $612.7M

Today’s biggest moves

Up

YDES
5.73 0.96 20.13%
PHAT
7.30 0.32 4.58%
DNA
10.66 0.41 4.00%
PTGX
141.86 5.35 3.92%
IVA
3.37 0.11 3.37%

Down

KRSA
31.00 (6.19) (16.64%)
SRZN
29.54 (4.14) (12.29%)
NGNE
28.31 (2.99) (9.54%)
LRMR
3.08 (0.24) (7.23%)
TTRX
12.49 (0.96) (7.16%)

All 616 companies

Open in screener
Ticker Company Market cap Price 1D P/E Net margin Revenue growth Dividend yield
VRTX Vertex Pharmaceuticals Incorporated 132.32b 526.19 0.73% 30.36 35.00% 10.23% —
REGN Regeneron Pharmaceuticals, Inc. 81.34b 788.04 (1.00%) 18.80 27.86% 9.29% —
MRNA Moderna, Inc. 78.77b 198.88 2.08% 0.00 (141.43%) (27.62%) —
ARGX argenex SE 60.20b 959.49 (0.28%) 34.61 32.20% 70.58% —
RVMD Revolution Medicines, Inc. 42.88b 204.97 2.56% 0.00 0.00% (8.81%) —
ONC BeOne Medicines Ltd. - Sponsored ADR 37.25b 360.85 0.24% 61.16 10.70% 34.35% —
RPRX Royalty Pharma PLC 34.35b 58.21 0.95% 40.14 32.02% 10.01% 3.09%
ALNY Alnylam Pharmaceuticals, Inc. 31.16b 255.96 2.55% 43.62 16.13% 95.14% 2.52%
INSM Insmed, Inc. 26.84b 117.83 (3.06%) 0.00 (76.94%) 185.76% —
ROIV Roivant Sciences Ltd. 25.64b 35.80 (0.91%) 0.00 (3,534.96%) (67.58%) —
INCY Incyte Corporation 25.48b 123.89 (0.44%) 15.24 27.71% 26.93% —
BNTX BioNTech SE Sponsored ADR 24.94b 98.52 (0.75%) 0.00 (65.75%) (3.33%) 1.33%
GMAB Genmab A/S Sponsored ADR 20.81b 35.32 1.41% 27.81 19.08% 22.26% —
ASND Ascendis Pharma A/S 15.68b 225.60 (2.21%) 16.27 71.20% 125.98% —
JAZZ Jazz Pharmaceuticals PLC 15.34b 237.95 0.71% 15.60 20.45% 12.59% —
EXEL Exelixis, Inc. 14.40b 58.16 0.24% 17.60 35.33% 9.23% —
SMMT Summit Therapeutics PLC 13.12b 15.61 (4.70%) 0.00 0.00% (61.03%) —
BBIO BridgeBio Pharma, Inc. 13.10b 65.57 (1.09%) 0.00 (97.03%) 202.39% —
HALO Halozyme Therapeutics, Inc. 13.08b 113.90 (1.15%) 32.36 24.86% 41.15% —
CORT Corcept Therapeutics Incorporated 12.87b 116.10 (2.03%) 223.27 6.53% 16.02% 0.31%
BMRN BioMarin Pharmaceutical Inc. 11.96b 60.26 (1.78%) 158.58 2.14% 11.20% —
MDGL Madrigal Pharmaceuticals, Inc. 11.86b 516.56 0.65% 0.00 (25.32%) 149.04% —
TECH Bio-Techne Corp 11.38b 72.61 0.06% 62.06 14.97% (0.38%) 0.37%
AXSM Axsome Therapeutics, Inc. 10.27b 195.09 (0.48%) 0.00 (24.68%) 56.87% —
KRYS Krystal Biotech, Inc. 10.21b 345.82 0.34% 41.86 54.82% 22.63% —
KYMR Kymera Therapeutics, Inc. 9.69b 111.95 (2.88%) 0.00 (285.33%) 134.84% —
ARWR Arrowhead Pharmaceuticals, Inc. 9.33b 65.92 (0.23%) 0.00 (47.79%) 16.13% —
IBRX ImmunityBio, Inc. 9.19b 8.44 (2.31%) 0.00 (598.56%) 192.92% —
CAI Caris Life Sciences,�Inc. 9.12b 31.98 (0.90%) 85.08 8.15% 96.36% —
CYTK Cytokinetics, Incorporated 8.98b 64.66 (1.52%) 0.00 (1,321.12%) (21.07%) —
PTGX Protagonist Therapeutics, Inc. 8.88b 141.86 3.92% 116.99 29.40% 34.81% —
TGTX TG Therapeutics, Inc. 8.80b 57.43 (0.16%) 18.89 55.22% 76.08% —
PCVX Vaxcyte, Inc. 8.47b 56.21 (1.21%) 0.00 0.00% — —
ABVX Abivax SA Sponsored ADR 8.23b 91.06 (4.02%) 0.00 0.00% — —
PRAX Praxis Precision Medicines, Inc. 7.87b 280.78 (0.36%) 0.00 0.00% 249.53% —
SYRE Spyre Therapeutics, Inc. 7.68b 85.69 (0.99%) 0.00 0.00% (81.84%) —
IONS Ionis Pharmaceuticals, Inc. 7.39b 44.50 1.57% 0.00 (64.66%) (7.41%) —
IMVT Immunovant, Inc. 7.11b 33.30 (2.06%) 0.00 0.00% — —
BLTE Belite Bio, Inc. Sponsored ADR 6.82b 167.33 (1.25%) 0.00 0.00% — —
RYTM Rhythm Pharmaceuticals, Inc. 6.77b 98.66 0.36% 0.00 (87.62%) 53.51% —
LGND Ligand Pharmaceuticals Incorporated 6.09b 301.52 0.83% 30.12 67.88% 54.89% 2.04%
CGON CG Oncology, Inc. 6.09b 67.15 (1.76%) 0.00 (3,602.68%) 840.79% —
SRRK Scholar Rock Holding Corporation 5.96b 48.63 0.31% 0.00 0.00% 213.65% —
MIRM Mirum Pharmaceuticals, Inc. 5.84b 89.70 0.38% 0.00 (139.18%) 44.02% —
ORKA Oruka Therapeutics, Inc. 5.69b 84.46 (1.20%) 0.00 0.00% — —
TVTX Travere Therapeutics, Inc. 5.66b 59.44 (1.95%) 0.00 (7.35%) 77.12% —
COGT Cogent Biosciences, Inc. 5.45b 32.31 2.80% 0.00 0.00% 110.23% —
CRSP CRISPR Therapeutics AG 5.39b 54.23 (2.64%) 0.00 (3,368.72%) (64.80%) —
PTCT PTC Therapeutics, Inc. 5.20b 62.67 0.63% 0.00 (3.80%) (42.84%) —
ERAS Erasca, Inc. 5.08b 14.25 (1.86%) 0.00 0.00% — —
DNTH Dianthus Therapeutics, Inc. 5.07b 88.55 (2.38%) 0.00 (10,096.95%) (60.77%) —
DFTX Definium Therapeutics, Inc. 4.94b 36.17 (1.52%) 0.00 0.00% — —
IOVA Iovance Biotherapeutics, Inc. 4.90b 11.00 1.85% 0.00 (89.09%) 34.55% —
EWTX Edgewise Therapeutics, Inc. 4.41b 39.34 (4.42%) 0.00 0.00% — —
VKTX Viking Therapeutics, Inc. 4.31b 35.56 (3.24%) 0.00 0.00% — —
TNGX Tango Therapeutics, Inc. 4.15b 24.92 1.18% 0.00 0.00% 48.29% —
ABCL AbCellera Biologics Inc. 4.15b 12.70 0.47% 0.00 (248.82%) 101.29% —
RLAY Relay Therapeutics, Inc. 3.91b 17.47 (0.96%) 0.00 (2,594.20%) (74.29%) —
CELC Celcuity, Inc. 3.88b 79.52 0.19% 0.00 0.00% — —
TLX Telix Pharmaceuticals Limited 3.86b 11.45 1.24% — — — —
ACAD ACADIA Pharmaceuticals Inc. 3.83b 20.68 (6.76%) 9.19 33.42% 11.75% —
XENE Xenon Pharmaceuticals Inc. 3.73b 36.94 (2.94%) 0.00 0.00% (8.15%) —
LEGN Legend Biotech Corporation Sponsored ADR 3.69b 19.11 0.26% 0.00 (7.20%) 59.55% —
IDYA IDEAYA Biosciences, Inc. 3.55b 36.69 0.19% 0.00 (74.75%) 901.18% —
TARS Tarsus Pharmaceuticals, Inc. 3.55b 75.69 (0.36%) 0.00 (7.67%) 105.17% —
ARQT Arcutis Biotherapeutics, Inc. 3.39b 26.92 2.47% 122.36 6.15% 76.11% —
DNLI Denali Therapeutics Inc. 3.36b 20.39 (0.39%) 0.00 (171.06%) 194.68% —
ELVN Enliven Therapeutics, Inc. 3.31b 44.75 (0.93%) 0.00 0.00% — —
RCUS Arcus Biosciences, Inc. 3.19b 24.97 (1.32%) 0.00 (393.16%) (55.34%) —
DYN Dyne Therapeutics, Inc. 3.14b 16.03 (2.91%) 0.00 0.00% — —
ZLAB Zai Lab Limited Unsponsored ADR 2.85b 24.98 (1.19%) 0.00 (41.86%) 5.10% —
PGEN Precigen, Inc. 2.78b 7.75 0.65% 0.00 (392.81%) 1,875.05% —
NAMS NewAmsterdam Pharma Company N.V. 2.72b 22.58 (0.70%) 0.00 (3,644.21%) (88.87%) —
QURE uniQure N.V. 2.67b 38.23 (0.23%) 0.00 (1,350.73%) 30.24% —
MBX MBX Biosciences, Inc. 2.67b 53.63 (3.18%) 0.00 0.00% — —
GPCR Structure Therapeutics Inc. Sponsored ADR 2.59b 35.93 (0.25%) 0.00 0.00% — —
IMNM Immunome, Inc. 2.56b 21.41 (5.01%) 0.00 0.00% 16.74% —
IRON Disc Medicine, Inc. 2.55b 65.24 (1.46%) 0.00 0.00% — —
BEAM Beam Therapeutics Inc. 2.55b 24.27 (1.58%) 0.00 (55.45%) 158.88% —
CLDX Celldex Therapeutics, Inc. 2.49b 31.10 (1.21%) 0.00 (33,883.77%) (88.27%) 2.16%
NRIX Nurix Therapeutics, Inc. 2.45b 23.01 (2.41%) 0.00 (928.44%) (58.40%) —
HRMY Harmony Biosciences Holdings, Inc. 2.40b 41.26 0.24% 13.18 18.88% 24.25% —
VERA Vera Therapeutics, Inc. 2.40b 32.54 (1.92%) 0.00 0.00% — —
SLS SELLAS Life Sciences Group, Inc. 2.37b 11.61 (3.09%) 0.00 0.00% — —
VRDN Viridian Therapeutics, Inc. 2.36b 20.47 (0.92%) 0.00 (544.06%) 23,220.33% —
MLYS Mineralys Therapeutics, Inc. 2.35b 25.86 (2.75%) 0.00 0.00% — —
PHVS Pharvaris N.V. 2.30b 32.02 (2.94%) 0.00 0.00% — —
AUPH Aurinia Pharmaceuticals Inc 2.21b 16.44 (0.96%) 6.88 100.84% 19.76% —
OCUL Ocular Therapeutix, Inc. 2.16b 9.65 (1.73%) 0.00 (579.10%) (8.14%) —
NKTR Nektar Therapeutics 2.14b 57.06 (3.91%) 0.00 (287.84%) (27.15%) —
ADMA ADMA Biologics Inc 2.13b 9.38 (1.47%) 13.03 32.98% 8.04% —
RXRX Recursion Pharmaceuticals, Inc. 2.11b 3.74 (3.86%) 0.00 (945.92%) (15.08%) —
PVLA Palvella Therapeutics, Inc. 2.10b 138.16 (5.42%) 0.00 0.00% 142.89% —
KOD Kodiak Sciences Inc. 2.09b 32.35 (2.62%) 0.00 0.00% — —
TRVI Trevi Therapeutics, Inc. 2.09b 14.41 (1.84%) 0.00 0.00% — —
VCEL Vericel Corporation 2.03b 39.71 0.92% 82.63 7.91% 22.95% —
URGN Urogen Pharma 2.02b 41.35 0.29% 0.00 (51.73%) 100.27% —
NUVB Nuvation Bio Inc. 2.02b 5.74 0.17% 0.00 (88.19%) 1,083.56% —
MESO Mesoblast Limited 2.01b 15.12 (2.33%) 0.00 (1,091.71%) (26.54%) —
AGIO Agios Pharmaceuticals, Inc. 2.00b 32.58 (0.97%) 0.00 (418.24%) 140.58% —

Updated 26 September 2026